Correction to: Birth defects reporting and the use of dydrogesterone: a disproportionality analysis from the World Health Organization pharmacovigilance database (VigiBase)

Human reproduction open · 2025 · vol. 2025(2) , pp. hoaf029 · doi:10.1093/hropen/hoaf029 · PMID:40463509 · PMC12132097
Other OA: gold CC-BY-4.0
📄 Open PDF View on PubMed View at publisher
⚙ AI-generated summary by qwen3.7-flash, 2026-09-07 ⓘ

This correction addresses errors in the previously published disproportionality analysis from the World Health Organization pharmacovigilance database regarding birth defects reporting and dydrogesterone use.

One-sentence paraphrase of the abstract; not a substitute for reading it. No clinical advice. How this works

Abstract

[This corrects the article DOI: 10.1093/hropen/hoae072.].

My notes (saved in your browser only)

Citation neighborhood (no data yet)

We don't have any in-corpus citations linked to this paper yet. This is a recent paper (2025) — citers typically take a year or two to land, and the OpenAlex reference graph may still be filling in.

Source provenance

europepmc
last seen: 2026-10-25T09:32:14.900964+00:00
pubmed
last seen: 2026-10-08T21:49:45.452123+00:00
License: CC-BY-4.0 · commercial use OK · attribution required
Per Europe PMC